Form 8-K - Current report:
SEC Accession No. 0001104659-25-075748
Filing Date
2025-08-08
Accepted
2025-08-08 17:17:38
Documents
13
Period of Report
2025-08-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2522780d1_8k.htm   iXBRL 8-K 34235
2 EXHIBIT 10.1 tm2522780d1_ex10-1.htm EX-10.1 126266
  Complete submission text file 0001104659-25-075748.txt   358954

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE snpx-20250806_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snpx-20250806_pre.xml EX-101.PRE 22362
5 XBRL TAXONOMY EXTENSION SCHEMA snpx-20250806.xsd EX-101.SCH 3020
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2522780d1_8k_htm.xml XML 3802
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005
TAO Synergies Inc. (Filer) CIK: 0001571934 (see all company filings)

EIN.: 461585656 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40458 | Film No.: 251199450
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)